| __timestamp | Intra-Cellular Therapies, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 293000 |
| Thursday, January 1, 2015 | 87718074 | 1002000 |
| Friday, January 1, 2016 | 93831530 | 888000 |
| Sunday, January 1, 2017 | 79419009 | 19623000 |
| Monday, January 1, 2018 | 132166913 | 30421000 |
| Tuesday, January 1, 2019 | 89124838 | 34794000 |
| Wednesday, January 1, 2020 | 65782137 | 28304000 |
| Friday, January 1, 2021 | 88845513 | 56886000 |
| Saturday, January 1, 2022 | 134715000 | 100894000 |
| Sunday, January 1, 2023 | 180142000 | 159765000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Intra-Cellular Therapies, Inc. has consistently increased its R&D spending, peaking in 2023 with a 750% increase from its 2014 levels. This upward trend underscores the company's dedication to advancing its therapeutic pipeline.
Viridian Therapeutics, Inc., on the other hand, has shown a more volatile pattern. Starting with minimal R&D expenses in 2014, the company saw a dramatic rise by 2023, marking a staggering 54,000% increase. This surge reflects Viridian's strategic pivot towards aggressive research initiatives.
Both companies exemplify the dynamic nature of the biotech industry, where strategic R&D investments can lead to groundbreaking innovations.
Research and Development Investment: Biogen Inc. vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Viridian Therapeutics, Inc.
Intra-Cellular Therapies, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Intra-Cellular Therapies, Inc. or Vericel Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ImmunityBio, Inc.
Intra-Cellular Therapies, Inc. vs MannKind Corporation: Strategic Focus on R&D Spending
R&D Insights: How Intra-Cellular Therapies, Inc. and Travere Therapeutics, Inc. Allocate Funds
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for HUTCHMED (China) Limited and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Iovance Biotherapeutics, Inc. and Viridian Therapeutics, Inc.